STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 169 filers reported holding BRIDGEBIO PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.

Quarter-by-quarter ownership
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$861,851
+54.1%
32,683
+0.5%
0.00%
+100.0%
Q2 2023$559,224
-5.2%
32,513
-8.6%
0.00%0.0%
Q1 2023$589,966
+117.6%
35,5830.0%0.00%0.0%
Q4 2022$271,142
-35.1%
35,583
-15.5%
0.00%0.0%
Q3 2022$418,000
+9.4%
42,0930.0%0.00%0.0%
Q2 2022$382,000
-10.5%
42,093
+0.0%
0.00%0.0%
Q1 2022$427,000
-39.2%
42,0830.0%0.00%0.0%
Q4 2021$702,000
-64.4%
42,083
-0.0%
0.00%
-75.0%
Q3 2021$1,972,000
-22.4%
42,084
+0.9%
0.00%
-20.0%
Q2 2021$2,542,000
+14.9%
41,704
+16.1%
0.01%
+25.0%
Q1 2021$2,213,000
-2.9%
35,922
+12.0%
0.00%
-20.0%
Q4 2020$2,280,000
+78.8%
32,060
-5.6%
0.01%
+66.7%
Q3 2020$1,275,000
+27.5%
33,970
+10.7%
0.00%
+50.0%
Q2 2020$1,000,000
+123.7%
30,680
+99.2%
0.00%
+100.0%
Q1 2020$447,00015,4000.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders